scispace - formally typeset
M

Maki Saitoh

Researcher at Massachusetts Institute of Technology

Publications -  5
Citations -  2182

Maki Saitoh is an academic researcher from Massachusetts Institute of Technology. The author has contributed to research in topics: mTORC2 & PI3K/AKT/mTOR pathway. The author has an hindex of 5, co-authored 5 publications receiving 1902 citations.

Papers
More filters
Journal ArticleDOI

Rapamycin-Induced Insulin Resistance Is Mediated by mTORC2 Loss and Uncoupled from Longevity

TL;DR: In this article, the authors demonstrate that rapamycin disrupted a second mTOR complex, mTORC2, in vivo and that mTORc2 was required for the insulin-mediated suppression of hepatic gluconeogenesis.

mTOR Complex 2 Is Required for the Development of Prostate Cancer Induced by Pten Loss in Mice

TL;DR: It is shown that transformed human prostate epithelial cells lacking PTEN require mTORC2 to form tumors when injected into nude mice, and that deleting one copy of Rictor protects Pten heterozygous mice from prostate cancer.
Journal ArticleDOI

mTOR Complex 2 Is Required for the Development of Prostate Cancer Induced by Pten Loss in Mice

TL;DR: In this article, it was shown that transformed human prostate epithelial cells lacking PTEN require mTORC2 to form tumors when injected into nude mice and that Rictor is a haploinsufficient gene and that deleting one copy protected Pten heterozygous mice from prostate cancer.
Journal ArticleDOI

Transformation of Different Human Breast Epithelial Cell Types Leads to Distinct Tumor Phenotypes

TL;DR: Compared tumors derived from two different normal human mammary epithelial cell populations, one of which was isolated using a new culture medium, found that the pre-existing differences between BPECs and HMECs strongly influence the phenotypes of their transformed derivatives.

Rapamycin-Induced Insulin Resistance Is Mediated by mTORC2 Loss and Uncoupled from Longevity

TL;DR: It is demonstrated that rapamycin disrupted a second mTOR complex, m TORC2, in vivo and that mTORC2 was required for the insulin-mediated suppression of hepatic gluconeogenesis and was sufficient to extend life span independently from changes in glucose homeostasis.